V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210030131 | 210009579 | 0 | 12.05 | Curative (C) | 2018-05-12 | 2018-05-22 | CNS ATRT Methotrexate Intrathecal | 02 | N | 210019143 | NOT MATCHED |
| 210030132 | 210009581 | 0 | 14.7 | Curative (C) | 2017-09-19 | 2017-09-19 | CNS LGG 2004 03 cons vinc + carbo | N | N | 210019150 | NOT MATCHED |
| 210030133 | 210009583 | null | 7.8 | Curative (C) | 2017-06-08 | 2017-06-08 | CNS ATRT ICE | N | null | 210019166 | NOT MATCHED |
| 210030134 | 210009587 | 0 | 21.5 | Curative (C) | 2016-03-02 | 2016-03-02 | CNS LGG 2004 03 cons vinc +cyclo | Y | N | 210019168 | NOT MATCHED |
| 210030135 | 210009588 | null | 56.8 | Curative (C) | 2013-11-17 | 2014-02-13 | CNS Medbl HR Carboplatin/Vinc/Cyclophos/GCSF | 2 | N | 210019169 | NOT MATCHED |
| 210030136 | 210009589 | 1.29 | 24.5 | Curative (C) | 2013-11-07 | 2014-01-30 | ALL ALLR3: S/IR Cons: Wk 7-8 | 02 | null | 210019174 | NOT MATCHED |
| 210030137 | 210009591 | 0.92 | 22.3 | Curative (C) | 2017-05-04 | 2017-05-14 | CNS High Grade Glioma PCV | N | N | 210019177 | NOT MATCHED |
| 210030138 | 210009593 | null | 47.8 | Curative (C) | 2017-03-30 | 2017-03-30 | CNS Medbl HR Vinc + Carbo | null | N | 210019179 | NOT MATCHED |
| 210030139 | 210020090 | 0.94 | 21.7 | Curative (C) | 2015-09-03 | 2015-10-26 | CNS LGG Temozolomide | N | N | 210019183 | NOT MATCHED |
| 210030141 | 210020092 | 0 | 16.5 | Curative (C) | 2017-03-17 | 2017-05-03 | CNS Medbl HR Carboplatin/Vinc/Cyclophos/GCSF | N | N | 210019193 | NOT MATCHED |
| 210030142 | 210009600 | 0 | 6.1 | Curative (C) | 2016-10-23 | 2017-03-05 | CNS Headstart II Myeloablation | 2 | N | 210019195 | NOT MATCHED |
| 210030143 | 210009603 | 1.02 | 10.7 | Curative (C) | 2014-01-21 | 2014-03-11 | CNS Epen2007 09 Baby Brn vinc+carbo | N | N | 210019197 | NOT MATCHED |
| 210030144 | 210009603 | 1.87 | 27.6 | Curative (C) | 2013-07-17 | 2013-08-09 | CNS Medbl HR Vinc + HD Mtx | N | N | 210019197 | NOT MATCHED |
| 210030145 | 210009607 | 1.22 | 10.6 | Curative (C) | 2015-10-18 | 2015-12-27 | CNS High Grade Glioma PCV | Y | N | 210019200 | NOT MATCHED |
| 210030146 | 210030853 | null | 16.3 | Palliative (P) | null | 2015-10-04 | CNS Ependymoma II Cisplatin | 2 | N | 210019201 | NOT MATCHED |
| 210030148 | 210009611 | null | 30.4 | Curative (C) | 2014-12-29 | 2015-01-24 | CNS Headstart II A Ind 4,5 int | Y | N | 210019213 | NOT MATCHED |
| 210030149 | 210020100 | null | 10.8 | Curative (C) | 2013-10-04 | 2014-02-28 | CISPLATIN + CYCLOPHOSPHAMIDE + VINCRISTINE | N | N | 210019247 | NOT MATCHED |
| 210030150 | 210034922 | null | 4.8 | Palliative (P) | 2014-12-04 | 2014-12-17 | ALL Ph+ve Dasatinib Cons HR2 Pasp | 01 | N | 210019248 | NOT MATCHED |
| 210030151 | 210009614 | null | 103.7 | Curative (C) | 2015-09-16 | 2016-03-12 | CNS Medbl HR Vinc + HD Mtx | N | N | 210019255 | NOT MATCHED |
| 210030152 | 210009615 | 1.34 | 6.5 | Neo-adjuvant (N) | 2018-03-07 | 2018-03-09 | CNS Headstart II A Ind 4,5 int | Y | N | 210019256 | NOT MATCHED |
| 210030153 | 210020104 | 0 | 27.4 | Curative (C) | 2013-01-31 | 2013-03-01 | CNS Headstart II A Ind 4,5 int | N | N | 210019257 | NOT MATCHED |
| 210030154 | 210020105 | 1.56 | null | Curative (C) | 2018-04-18 | 2018-07-24 | TEMOZOLOMIDE + DEPATUXIZUMAB | N | N | 210019262 | NOT MATCHED |
| 210030156 | 210009619 | 1.09 | 6.8 | Neo-adjuvant (N) | null | 2014-08-28 | CNS Epen2007 09 Baby Brn vinc+carbo | N | N | 210019265 | NOT MATCHED |
| 210030157 | 210009621 | null | 10.9 | Curative (C) | 2015-02-26 | 2016-04-05 | CNS LGG 2004 03 con vinc +cisplatin | N | N | 210019278 | NOT MATCHED |
| 210030158 | 210009624 | null | 9.1 | Curative (C) | null | 2017-09-14 | CNS Ependy II Cisp/Vinc | N | Y | 210019290 | NOT MATCHED |
| 210030159 | 210009626 | null | 10.7 | Neo-adjuvant (N) | 2016-08-19 | 2016-09-10 | ALL Ph+ve 1B | N | N | 210019301 | NOT MATCHED |
| 210030160 | 210020112 | null | 9.3 | Palliative (P) | 2013-03-14 | 2013-05-28 | CNS Medbl HR Carboplatin/Vinc/Cyclophos/GCSF | N | Y | 210019307 | NOT MATCHED |
| 210030161 | 210009628 | null | 30.5 | Curative (C) | 2016-08-10 | 2016-08-10 | CNS Medbl HR Maint vinc+ Lomustine | Y | N | 210019308 | NOT MATCHED |
| 210030162 | 210009629 | null | 11.2 | Disease modification (D) | 2016-12-21 | 2017-04-12 | PNET 4 HIT-SIOP Chemo + RT | N | N | 210019310 | NOT MATCHED |
| 210030163 | 210020115 | null | null | Disease modification (D) | 2014-11-18 | 2015-06-01 | CNS ATRT ICE | Y | N | 210019312 | NOT MATCHED |
| 210030164 | 210030863 | null | 35.3 | Curative (C) | 2016-07-28 | 2016-11-27 | CNS High Grade Glioma PCV | 02 | N | 210019314 | NOT MATCHED |
| 210030165 | 210009632 | null | 24.4 | Curative (C) | 2014-03-28 | 2014-07-27 | CISPLATIN + CYCLOPHOSPHAMIDE + VINCRISTINE | 2 | N | 210019319 | NOT MATCHED |
| 210030166 | 210009635 | 1.29 | 7.8 | Curative (C) | 2016-05-09 | 2016-09-24 | CNS High Grade Glioma PCV | N | N | 210019323 | NOT MATCHED |
| 210030167 | 210009637 | 0 | 9.5 | Curative (C) | 2013-09-29 | 2014-03-02 | ALL Interfant 06 OCTADAD pt I PAsp | 02 | N | 210019329 | NOT MATCHED |
| 210030168 | 210009638 | 1.39 | 14.05 | Disease modification (D) | 2015-10-09 | 2015-10-11 | null | Y | N | 210019333 | NOT MATCHED |
| 210030169 | 210009641 | 0.68 | 13.5 | Curative (C) | 2015-02-11 | 2015-02-11 | CYTARABINE + FLUDARABINE + IDARUBICIN + PEGASPARAGINASE | N | Y | 210019345 | NOT MATCHED |
| 210030170 | 210009642 | null | 54.6 | Disease modification (D) | 2014-06-16 | 2014-06-16 | ALL Int Guide A Int Maint Ph III | 2 | Y | 210019348 | NOT MATCHED |
| 210030171 | 210009644 | 1.72 | 17.3 | Curative (C) | 2018-05-21 | 2018-07-30 | ALL Interfant 06 Protocol 1B | N | N | 210019353 | NOT MATCHED |
| 210030172 | 210009647 | 0.83 | 118.6 | Curative (C) | null | 2015-09-01 | ALL UKALL2011 Del Int A Pt1 (Erw) | N | N | 210019363 | NOT MATCHED |
| 210030173 | 210009648 | 1.77 | 44.3 | Disease modification (D) | 2019-05-23 | 2019-05-24 | CNS Headstart II Myeloablation | N | Y | 210019376 | NOT MATCHED |
| 210030174 | 210020129 | 1.02 | null | Adjuvant (A) | 2014-01-31 | 2013-12-23 | ALL UKALL2011 Ind C Std Dex (PAsp) | N | N | 210019377 | NOT MATCHED |
| 210030175 | 210009650 | 1.06 | 90.6 | Curative (C) | 2016-03-20 | 2016-09-30 | ALL UKALL2011 Ind C Std Dex (PAsp) | N | N | 210019384 | NOT MATCHED |
| 210030176 | 210009652 | 0 | 13.6 | Disease modification (D) | 2015-10-11 | 2015-10-16 | CNS Ependy II Cisplatin + valproate | N | N | 210019389 | NOT MATCHED |
| 210030177 | 210009652 | 1.34 | 63.4 | Adjuvant (A) | 2017-04-20 | 2017-05-05 | ALL Interfant 06 | N | null | 210019389 | NOT MATCHED |
| 210030178 | 210009655 | 1.79 | 60.6 | Palliative (P) | 2013-12-12 | 2015-05-30 | CNS LGG 2004 03 cons vinc +cyclo | N | N | 210019402 | NOT MATCHED |
| 210030179 | 210009656 | null | null | Curative (C) | 2013-02-18 | 2013-07-22 | null | N | N | 210019415 | NOT MATCHED |
| 210030180 | 210009657 | 1.56 | 7.2 | Curative (C) | 2017-12-25 | 2017-12-26 | ALL Ph+ve Cons HR2 Pasp | Y | N | 210019416 | NOT MATCHED |
| 210030181 | 210009659 | null | 8.1 | Adjuvant (A) | 2017-08-30 | 2017-08-31 | ALL Int Guide A Cons Ph II | N | Y | 210019422 | NOT MATCHED |
| 210030182 | 210009660 | 1.17 | 10.3 | Curative (C) | 2016-06-29 | 2016-08-11 | ALL Interfant 06 OCTADAD pt I PAsp | Y | N | 210019426 | NOT MATCHED |
| 210030183 | 210026917 | 1.04 | 80.6 | Curative (C) | 2016-10-27 | 2016-10-27 | ALL ALLR3: S/IR Con Wk6 (PAsp)HDMTx | N | N | 210019444 | NOT MATCHED |